Articles

Information exchange to improve patient care

Among other recent moves, LabCorp forms collaboration with New Jersey Primary Care Association
Written byJeffrey Bouley
| 3 min read

BURLINGTON, N.C.—Increasingly, life-sciences companies and others in the life-sciences field have worked toward methods of more heavily personalizing patient monitoring and care through diagnostics, as a way of better understanding when intervention is needed and how a patient is responding to treatment. It’s an important aspect of personalized medicine efforts, as well as a help to many clinical trial efforts.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.